A Phase II Study of Pembrolizumab And Tamoxifen Among Women With Advanced Hormone Receptor Positive Breast Cancer And Esr1 Mutation
Latest Information Update: 04 Aug 2022
At a glance
- Drugs Pembrolizumab (Primary) ; Tamoxifen (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
Most Recent Events
- 27 Mar 2019 New trial record